Use of the SSRI antidepressant Zoloft during pregnancy has been linked to an increased risk of serious and potentially life-threatening health problems for babies, including a risk of heart defects, persistent pulmonary hypertension in newborns (PPHN), lung defects, abdominal defects, cranial defects and other malformations.
ZOLOFT LAWSUIT STATUS: Lawyers are reviewing potential claims for children who may be entitled to compensation through a Zoloft birth defect lawsuit as a result of the drug maker’s failure to warn about the risks associated with use of the medication during pregnancy.
OVERVIEW: Zoloft (sertraline) is manufactured by Pfizer, but generic Zoloft is available from a number of drug makers. The medication is a second generation antidepressant, known as a selective serotonin reuptake inhibitor (SSRI), which is the same class of drugs as Paxil.
According to allegations raised by parents of many children born with defects or malformations, the drug makers failed to adequately research the side effects of Zoloft when used during pregnancy and failed to adequately warn women and the medical community about the potential health problems that could be suffered by unborn children exposed to the medication.
ZOLOFT BIRTH DEFECT PROBLEMS: Despite a number of studies and reports suggesting a potential link between Zoloft and birth defects, the manufacturers have failed to provide sufficient information to pregnant women or women of child-bearing potential, so that steps could be taken to avoid using Zoloft while pregnant.
In November 2006, the FDA added warnings about a potential risk of persistent pulmonary hypertension in newborns (PPHN) from Zoloft and other newer antidepressants when taken after the 20th week of pregnancy. The side effects of Zoloft and other similar medications were linked to a six times greater risk of PPHN.
To read the FDA’s warning, click here: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm126522.htm
In June 2007, studies found an association between the use of antidepressants like Zoloft early in the pregnancy and a risk of abnormal skull development, gastrointestinal abnormality and brain defects.
In September 2009, a study published in the British Medical Journal found that SSRI antidepressants like Zoloft increase the risk of heart defects when taken during the first trimester, a time when many women do not even know they are pregnant.
Potential Zoloft birth defects could include:
- Persistent Pulmonary Hypertension in Newborns (PPHN)
- Ventrical Septal Defect (VSD)
- Atrial Septal Defect
- Tetralology of the Fallot
- Transposition of the Great Arteries
- Hypoplastic Left Heart Syndrome
- Hypoplastic Right Heart Syndrome
- Patent Ductus Arteriosus
- Bicuspid Aortic Valve
- Tricuspid Stensosi
- Cleft Mitral Valve
- Neural Tube Defect
- Gastrointestinal Defect
- Spina Bifida
- Limb Defects
- Club Foot
For more information or to discuss your potential Zoloft birth defect claim, at no cost or obligation, contact us or call us at 954-572-7200. We welcome your inquiries.